VCYT Q4 2018 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M+31.4% YoY

Gross Profit

$17M66.2% margin

Operating Income

-$3M-11.9% margin

Net Income

-$3M-12.1% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+9.7%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$121M

Total Liabilities

$41M

Stockholders' Equity

$80M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$20M	+31.4%
Gross Profit	$17M	$12M	+44.1%
Operating Income	-$3M	-$6M	+49.4%
Net Income	-$3M	-$8M	+63.2%